Skip to main content
OpenTrials
Completed

NCT Number: NCT03030742

Postpartum Opioid Prescribing Patterns and Patient Utilization

This study seeks to investigate the prescribing patterns and patient utilization of opioid pain medication in the postpartum setting. Postpartum women will be surveyed prior to hospital discharge and again at 2-4 weeks postpartum in order to assess the number of opioid tablets they used (in relation to the number prescribed), pain satisfaction, and storage/disposal of any remaining opioid tablets.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Northwestern University

Chicago, Illinois, 60611, United States

About this study

Opiate abuse is a national epidemic and has paralleled the increase in opioid prescriptions, with diversion of surplus medication playing a key contributing role. As the majority of reproductive age women in the U.S. will experience childbirth, understanding opioid prescription patterns and patient opioid utilization in the postpartum period is critical.

Postpartum women will be recruited during a 9-month period to take part in pre-hospital discharge and 2-4 week postpartum surveys to prospectively assess opioid medication use with regard to quantity of opioid tablets prescribed and quantity used, storage and disposal of unused opioids and satisfaction with pain control.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women who deliver during the recruitment period
  • English-speaking
  • Opiate-naïve (as determined by admission medication reconciliation)
  • Receive oral opioid medications during inpatient postpartum admission
  • 18 years or older

Exclusion criteria

  • Contraindication to NSAID use
  • Required use of general anesthesia without concurrent neuraxial analgesia
  • Undergo hysterectomy, or unanticipated surgical procedures during the postpartum period
  • Are admitted to the intensive care unit during their admission.

Treatment and study plan

Survey

Other

A survey will be administered at two time points (time of hospital discharge and 2-4 weeks postpartum) to determine:

  • Satisfaction with pain control 2-4 weeks postpartum
  • Patient-reported use of opioid medication postpartum (receipt of prescription, filling of prescription, if refill was obtained, and number of opioid pills remaining at the time of follow-up)
  • Patient characteristics associated with high opioid use
  • Methods of storage and disposal of unused opioids

Other names: Survey/Questionnaire

Primary outcomes

  1. Postpartum outpatient opioid use

    Time frame: 8 weeks

    Self reported number of opioid tablets used at time of postpartum survey administered 2-4 weeks postpartum

Secondary outcomes

  1. Satisfaction with outpatient pain control

    Time frame: 8 weeks from time of hospital discharge

    Satisfaction with pain control at the time of postpartum survey administered 2-4 weeks postpartum

  2. Proper disposal/storage of remaining opioid tablets

    Time frame: 8 weeks from time of discharge

    Proportion of patients who report proper disposal/storage of remaining opioid tablets at the time of postpartum survey administered 2-4 weeks postpartum

  3. High opioid use

    Time frame: 8 weeks from time of hospital discharge

    Comparison of characteristics of women with >50% remaining versus <50% remaining of prescribed opioid tablets

Sponsors and collaborators

Lead sponsor

Northwestern University

Other

Collaborators

  • Society for Maternal-Fetal Medicine

Registry information

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Jan 25, 2017
Registry last updated
Feb 25, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.